ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) 2020 Annual Meeting of Stockholders June 23, 2020 10:00 AM ET
Company Participants
Steve Biggar - Chairman of the Board
Steve Davis - Chief Executive Officer
Laura Brege - Board of Directors
Jim Daly - Board of Directors
Ed Harrigan - Board of Directors
Serge Stankovic - President
Austin Kim - Executive Vice President and General Counsel and Secretary
Elena Ridloff - Executive Vice President and Chief Financial Officer
Michael Yang - Executive Vice President and Chief Commercial Officer
Mark Johnson - Vice President of Investor Relations
Operator
Hello, and welcome to the Annual Meeting of Stockholders of ACADIA Pharmaceuticals Inc. Please note that today's meeting is being recorded.
It is now my pleasure to turn today’s meeting over to Steve Biggar, Chairman of the Board of Directors of the ACADIA Pharmaceuticals. Mr. Biggar, the floor is yours.
Steve Biggar
Good morning, everyone. My name is Steve Biggar, and I am the Chairman of the Board of Directors of ACADIA Pharmaceuticals. I'd like to welcome you to the 2020 Annual Meeting of Stockholders, which is being [technical difficulty] virtually for the first time this year, obviously, due to the COVID-19 pandemic. I very much hope to that all of you are healthy and safe in these extraordinary times for our country and for the world.
Before I call the meeting to order, I'd like to introduce you to the other members of the Board and our executive officers who are with us today. The other members of the Board present today are Steve Davis, who is also our Chief Executive Officer; Laura Brege, Jim Daly and Ed Harrigan. The other executive officers of ACADIA who are present are Serge Stankovic, our President; Austin Kim, our Executive Vice President and General Counsel and Secretary; Elena Ridloff, Executive Vice President and Chief Financial Officer; and Michael Yang, our Executive Vice President
- Read more current ACAD analysis and news
- View all earnings call transcripts